Neoadjuvant PD-1/PD-L1 inhibitors combined with chemotherapy had a higher ORR than mono-immunotherapy in untreated HNSCC: Meta-analysis
Shaoshi Chen, Yifan Yang, Ru Wang, Jugao Fang
Topics & Concepts
MedicineImmunotherapyInternal medicineOncologyChemotherapySubgroup analysisAdverse effectMeta-analysisRadiation therapyCancerCancer Immunotherapy and BiomarkersColorectal and Anal CarcinomasBladder and Urothelial Cancer Treatments